Leukemia drug proves effective in long term

The developer of Gleevec, approved in 2001 to treat leukemia, says the drug has proven to be highly effective, with an analysis showing 89% of patients with a rare form of leukemia are alive and well after five years of treatment. The drug, produced by Novartis, controls leukemia by suppressing a biochemical misstep in cells, but it is not a cure.

View Full Article in:

Newsday (Long Island, N.Y.) (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY